OVERVIEW OF THE KEY AMENDMENTS TO THE RULES OF THE STATE REGISTRATION OF MAXIMUM SELLING PRICES FOR MEDICINES INCLUDED INTO THE LIST OF ESSENTIAL AND VITALLY IMPORTANT PRODUCTS

Abstract

In this article we analyse key amendments that came into force as of October 2015 in the sphere of the price regulation for medicines included into the list of essential and vitally important products.

Keywords

• edl medicines
• maximum selling prices
• price regulations
• federal antimonopoly